(Q41475050)

1 October 2017

1 reference

title

Selecting and validating biologic markers for drug development (English)

1 reference

1 October 2017

Colburn WA

1

1 reference

1 October 2017

publication date

1 May 1997

1 reference

The Journal of Clinical Pharmacology

1 October 2017

published in

1 reference

1 October 2017

volume

37

1 reference

1 October 2017

issue

5

1 reference

1 October 2017

page(s)

355-362

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04313.X

1 October 2017

1 reference

Surrogate biochemical markers: precise measurement for strategic drug and biologics development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04313.X

Clinical trial monitoring: hit or miss?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04313.X

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04313.X

Efficacy measures: surrogates or clinical outcomes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04313.X

A nonparametric subject-specific population method for deconvolution: I. Description, internal validation, and real data examples

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04313.X

A nonparametric subject-specific population method for deconvolution: II. External validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04313.X

Angiotensin II receptor blockade: an innovative approach to cardiovascular pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04313.X

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04313.X

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04313.X

HIV viral load markers in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04313.X

Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04313.X

Utility of illness severity scoring for prediction of prolonged surgical critical care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04313.X

10.1002/J.1552-4604.1997.TB04313.X

21 January 2018

Identifiers

DOI

1 reference

1 October 2017

1 reference